Neurobell secured $5.5M to support the US launch of Luna, its AI-enabled EEG monitor for detecting neonatal seizures. The round was led by Irish investment firm Elkstone, with participation from US health system Parkview Health alongside existing backers Furthr VC, Atlantic Bridge, and Enterprise Ireland. Roughly two-thirds of neonatal seizures show no outward symptoms, and delayed detection compounds the risk of long-term brain damage. The funding will support Neurobell's FDA submission and a new US office in Fort Wayne, Indiana.